Status:
UNKNOWN
Mucus Solids Concentration in Patients With Bronchiectasis
Lead Sponsor:
Universidad San Jorge
Collaborating Sponsors:
Hospital Clinic of Barcelona
Asociación Murciana de Fibrosis Quistica
Conditions:
Bronchiectasis
Eligibility:
All Genders
18+ years
Brief Summary
There is a need for biomarkers that can rapidly and sensitively detect therapeutic benefits of therapies designed to "rehydrate" airways and monitor disease severity and progression. In this study the...
Detailed Description
Prospective cross-sectional study of repeated measurements. The recruitment will be performed in 3 different cities of Spain: Zaragoza, Barcelona and Murcia. Subjects will be asked to repeatedly coll...
Eligibility Criteria
Inclusion
- Confirmed diagnosis of CF (confirmed genetics) or diagnosis of non-CF bronchiectasis through high resolution computed tomography.
- Aged ≥ 18 years.
- Clinically stable at the time of recruitment.
- Chronic sputum production (able to produce spontaneous sputum daily).
- Current hypertonic saline user.
- Able to provide written informed consent and perform the trial.
Exclusion
- Current smoker or \>10 pack-year history of tobacco use.
- Patient in transplantation or retransplantation list.
Key Trial Info
Start Date :
December 21 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 1 2023
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT04310618
Start Date
December 21 2020
End Date
August 1 2023
Last Update
October 1 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Marta San Miguel Pagola
Zaragoza, Aragon, Spain, 50014